AF
BSX icon

Alerus Financial’s Boston Scientific BSX Stock Holding History

Alerus Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Sell
57,718
-19,316
-25% -$1.05M 0.11% 109
2026
Q1 		$4.83M Sell
77,034
-7,240
-9% -$579K 0.24% 62
2025
Q4 		$8.04M Sell
84,274
-521
-0.6% -$51.1K 0.39% 42
2025
Q3 		$8.28M Sell
84,795
-291
-0.3% -$30.1K 0.42% 40
2025
Q2 		$9.14M Sell
85,086
-413
-0.5% -$41.8K 0.66% 32
2025
Q1 		$8.63M Sell
85,499
-4,901
-5% -$494K 0.69% 33
2024
Q4 		$8.07M Sell
90,400
-7,207
-7% -$634K 0.62% 37
2024
Q3 		$8.18M Sell
97,607
-3,898
-4% -$307K 0.6% 40
2024
Q2 		$7.82M Sell
101,505
-1,834
-2% -$134K 0.58% 42
2024
Q1 		$7.08M Buy
103,339
+37,051
+56% +$2.38M 0.53% 48
2023
Q4 		$3.83M Buy
+66,288
New +$3.54M 0.31% 77
2022
Q2 		– Sell
-6,782
Closed -$301K – 169
2022
Q1 		$301K Sell
6,782
-6,105
-47% -$265K 0.03% 160
2021
Q4 		$547K Sell
12,887
-28,343
-69% -$1.19M 0.04% 146
2021
Q3 		$1.79M Sell
41,230
-1,021
-2% -$45.2K 0.16% 120
2021
Q2 		$1.81M Sell
42,251
-3,607
-8% -$152K 0.18% 118
2021
Q1 		$1.77M Sell
45,858
-33,895
-42% -$1.28M 0.19% 109
2020
Q4 		$2.87M Buy
79,753
+18,330
+30% +$661K 0.29% 90
2020
Q3 		$2.35M Buy
61,423
+11,414
+23% +$440K 0.26% 93
2020
Q2 		$1.76M Sell
50,009
-1,863
-4% -$67.1K 0.21% 94
2020
Q1 		$1.69M Buy
51,872
+2,766
+6% +$108K 0.23% 92
2019
Q4 		$2.22M Buy
49,106
+319
+0.7% +$13.3K 0.25% 88
2019
Q3 		$1.99M Buy
48,787
+6,515
+15% +$276K 0.26% 86
2019
Q2 		$1.82M Buy
+42,272
New +$1.63M 0.25% 90

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Alerus Financial's BSX Position: Q2 2026 in Review

Alerus Financial reduced its Boston Scientific (BSX) stake by 25% in Q2 2026, selling an estimated $1.05M and leaving 57,718 shares worth $2.46M. The position accounts for 0.11% of the portfolio, ranked #109.

Alerus Financial first reported a position in BSX in Q2 2019 and has held it in 23 quarters since. The position peaked at $9.14M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Alerus Financial held 57,718 shares of Boston Scientific worth $2.46M as of Q2 2026.
  • Alerus Financial sold 19,316 Boston Scientific shares in Q2 2026, an estimated $1.05M.
  • Boston Scientific made up 0.11% of Alerus Financial's portfolio in Q2 2026, its #109 holding.
  • Alerus Financial first reported a position in Boston Scientific in Q2 2019 and has held it in 23 quarters since.
  • Alerus Financial's Boston Scientific position peaked at $9.14M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Alerus Financial's 13F filing for Q2 2026, filed 14 Aug 2026.